Elevated expression of IFITM3 has been noted in B-cell acute lymphoblastic leukemia (B-ALL) and B-cell lymphomas, and B cell malignancies with high IFITM3 expression have poorer prognoses51. This evidence concerns the gene IFITM3 and B-cell non-Hodgkin lymphoma.